Ghost Tree Capital, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Ghost Tree Capital, LLC

  • $267 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$27.21 - $39.48 $952,350 - $1.38 Million
35,000 New
35,000 $1 Million
Q3 2018

Nov 14, 2018
SELL
$14.0 - $20.3 $9.8 Million - $14.2 Million
-700,000 Closed
0 $0
Q2 2018

Aug 14, 2018
SELL
$6.37 - $14.02 $637,000 - $1.4 Million
-100,000 Reduced 12.5%
700,000 $9.52 Million
Q1 2018

May 15, 2018
BUY
$3.72 - $7.64 $2.98 Million - $6.11 Million
800,000 New
800,000 $5.77 Million

Others Institutions Holding ARWR

# of Institutions
304
Shares Held
95.9M
Call Options Held
523K
Put Options Held
493K
View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $1.57B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Ghost Tree Capital, LLC Portfolio

Follow Ghost Tree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email